Cassian Yee, MD
Fred Hutchinson Cancer Research Center
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Dr. Yee is studying a new technique to treat women with late stage ovarian cancer. T cells are collected from patients and responder cells are enhanced. These are given back to the patient, where the patient’s immune system should recognize these cells and use them to fight the cancer.